0
Abstract: Poster Presentations |

THORACOSCOPIC TALC INSUFFLATION FOR THE MANAGEMENT OF TRANSUDATIVE PLEURAL EFFUSIONS FREE TO VIEW

Ahmed S. Al-Halfawy
Author and Funding Information

Facuty of Medicine- Cairo University, Cairo, Egypt


Chest


Chest. 2009;136(4_MeetingAbstracts):45S. doi:10.1378/chest.136.4_MeetingAbstracts.45S
Text Size: A A A
Published online

Abstract

PURPOSE:  This is a retrospective analysis of 37 patients with transudative pleural effusions of different etiologies, which have been managed by thoracoscopic talc insufflation as a mode of relieving their dyspnea.

METHODS:  This review included 37 patients with transudative pleural effusions according to Light's criteria. There were 15 females and 22 male patients. Their mean age was 54.2 years. There were 28 patients with hepatic hydrothorax, 4 patients with lymphoma, 2 patients with cancer breast, 2 patients whose diagnoses remained unidentified, and 1 patient with multiple myeloma. Their average pleural fluid/serum protein ratio was 0.39, and their average pleural fluid/serum LDH 0.47. Thoracoscopic talc insufflation was performed using 2 gms of asbestos free talc.

RESULTS:  Successful pleurodesis was achieved in 32 patients (86.4%) at the time of removal of the intercostal tube, while in 5 (13.5%), pleurodesis failed. Five of these 32 patients (15.6%) developed encysted pleural effusions that required no further interventions. Three months after the procedure, 29 patients were able to show for follow up. Of these, 22 patients had a sustained pleurodesis ((22 out of 29) (75.8%). Complications were minimal and mainly in the form of low grade fever in 14 patients (37.8%), chest pain in 9 patients (24.3%), and wound infection in 5 patients (13.5%).

CONCLUSION:  Thoracoscopic talc insufflation is a safe procedure in patients with recurrent transudative pleural effusions of different etiologies. Patients may require pre-procedure correction of their serum albumin and correction of their bleeding profiles.

CLINICAL IMPLICATIONS:  patients with symptomatic transudative pleural effusions of different etiologies could be safely managed with thoracoscopic talc insufflation.

DISCLOSURE:  Ahmed Al-Halfawy, No Financial Disclosure Information; No Product/Research Disclosure Information

Tuesday, November 3, 2009

12:45 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543